PluroGen Therapeutics provides clinically advanced and advantaged burn, wound, and skin care products.
PluroGen's core technology platform was developed by researchers and physicians in University of Virginia's (UVA) Plastic Surgery Research Laboratory beginning in the 1970's. Their co-founder, George T. Rodeheaver, Ph.D., is one of the inventors of this technology and has supervised the formulation and production at UVA of one of their first products for use on burn and chronic wound patients at the UVA Health System for the past fifteen years.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 18, 2012 | Angel | $1M | 1 | — | — | Detail |
Apr 13, 2007 | Seed | $1.70M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Keiretsu Forum | — | Angel |
Virginia Active Angel Network | — | Seed |